KADIAN SPENCE: Open Payments
NPI 1538935838 · VALLEY FORGE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,564 in 51 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $131 · 2025 $1,564
Food & beverage: $1,453Education: $111
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 16 | $504 |
| Teva Pharmaceuticals USA, Inc. | 6 | $277 |
| E.R. Squibb & Sons, L.L.C. | 5 | $271 |
| Supernus Pharmaceuticals, Inc. | 13 | $166 |
| ABBVIE INC. | 1 | $114 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $105 |
| Lundbeck LLC | 4 | $85 |
| Otsuka America Pharmaceutical, Inc. | 2 | $42 |
Products named: INGREZZA, COBENFY, Qelbree, AUSTEDO XR, VRAYLAR, CAPLYTA, REXULTI, ABILIFY MAINTENA.
Industry payments across PA — which companies pay providers there.
